Table 4.
Clinical outcome of the patients after treatment with hMG, hFSH, rFSH, or sequential hFSH/rFSH
| Characteristics | Group A hMG | Group B hFSH | Group C rFSH | Group D SequentialhFSH/rFSH | P value |
|---|---|---|---|---|---|
| Biochemical pregnancy rate (%) | 22 (55) | 22 (55) | 22 (55) | 28 (70) | 0.432 |
| Clinical pregnancy rate (%) (n) | 18 (45) | 15 (37.5) | 20 (50) | 23 (57.5) | 0.296 |
| Implantation rate per embryo transferred (%) | 15.6±17.9 | 15.55±25.69 | 22.7±27.6 | 25.2±24.6 | 0.176 |
| Live birth rate per clinical pregnancy (n) (%) | 11 (61.11) | 9 (60) | 16 (80) | 19 (82) | 0.614 |
| Abortion rate per clinical pregnancy (%) | 2 (11.11) | 2 (13.13) | 3 (15) | 8 (34.87) | 0.862 |
Significance was considered at P≤0.05